Veryan Medical

3D stent for peripheral vascular disease

placeHorsham, England, United Kingdom calendar_todayFounded 2003 groups35 employees language veryanmed.com

Registered entities

Social engagement

Social engagement: 14.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Imperial Innovations, Oxford Capital, Seroba Life Sciences, Nesta Impact Investments.

Investor typeCountShare
Venture capital240%
Private equity120%
Accelerator & incubator120%
Other / undisclosed120%

Recent activity

21 May 2026
Event
NCVH 2026
12 May 2026
Product launch
RevolutionTM Peripheral Atherectomy System
6 May 2026
Event
New Cardiovascular Horizons (NCVH) Annual Conference
Coming soon